A 2026 animal study found that the ketogenic diet significantly reduced autoimmune thyroid disease in mice by restoring balance between immune cell types and suppressing inflammation pathways. According to Gram Research analysis, mice with thyroid disease that ate a ketogenic diet for 4 weeks showed major decreases in thyroid-attacking antibodies, reduced thyroid inflammation, and restored immune system balance compared to mice eating normal food. However, this research was only conducted in mice, so human studies are needed before the keto diet can be recommended as a treatment for people with autoimmune thyroiditis.

A new study from Gram Research analysis found that the ketogenic diet may help reduce thyroid autoimmune disease in mice by calming down an overactive immune system. Researchers discovered that the keto diet lowered inflammation markers and restored balance between two types of immune cells that were fighting each other. While this is promising early research, it was only tested in mice so far. Scientists say the findings suggest the ketogenic diet could become a helpful treatment alongside traditional medicine for people with autoimmune thyroiditis, but human studies are needed to confirm these results.

Key Statistics

A 2026 animal study of 60 mice published in PLOS ONE found that the ketogenic diet reduced thyroid-attacking antibodies and restored immune cell balance in mice with autoimmune thyroid disease within 4 weeks of dietary intervention.

According to research reviewed by Gram, mice with induced autoimmune thyroiditis on a ketogenic diet showed suppressed HMGB1/NLRP3 inflammation pathways and decreased Th17 immune cells compared to mice eating normal food.

The 2026 study found that ketogenic diet intervention reversed thyroid lymphocytic infiltration and reduced multiple inflammation markers including TNF-α, IL-6, and IL-1β in mice with autoimmune thyroid disease.

The Quick Take

  • What they studied: Whether eating a ketogenic diet (very low carb, high fat) could help reduce thyroid disease caused by the immune system attacking the thyroid gland
  • Who participated: Sixty laboratory mice, divided into three groups: healthy mice eating normal food, mice with thyroid disease eating normal food, and mice with thyroid disease eating a ketogenic diet
  • Key finding: Mice with thyroid disease that ate the ketogenic diet for 4 weeks showed major improvements: inflammation markers dropped significantly, immune system balance was restored, and thyroid damage was reduced compared to mice eating normal food
  • What it means for you: This research suggests the ketogenic diet might help people with autoimmune thyroid disease, but this is very early-stage research done only in mice. Anyone with thyroid disease should talk to their doctor before making major diet changes, as the keto diet isn’t right for everyone and may interact with thyroid medications

The Research Details

Researchers used laboratory mice specially bred to develop thyroid disease similar to humans. They divided 60 mice into three groups: healthy mice eating normal food (the control group), mice with induced thyroid disease eating normal food, and mice with thyroid disease eating a ketogenic diet. The mice with thyroid disease were given iodine in their water for 8 weeks to trigger the disease, then one group switched to the keto diet for 4 weeks while the other continued normal food. Scientists then examined the mice’s thyroid tissue under a microscope, measured inflammation chemicals in their blood, and analyzed immune system markers to see what changed.

The ketogenic diet is very different from normal eating—it’s about 70-75% fat, 20-25% protein, and only 5-10% carbohydrates. This extreme shift in what the body burns for energy (fat instead of sugar) appears to trigger changes in how the immune system works. The researchers measured dozens of different markers to understand exactly how the keto diet affected the immune system’s attack on the thyroid.

This type of animal study is important because it lets scientists test whether a treatment works before trying it in humans, where testing is more complicated and risky. However, results in mice don’t always translate to humans, so this research is really just the first step.

Autoimmune thyroid disease affects millions of people worldwide and current treatments focus mainly on replacing thyroid hormones or suppressing the entire immune system, which can have side effects. Finding a dietary approach that might help calm the specific immune problem without strong medications could be valuable. This study is important because it shows exactly which immune system pathways the keto diet affects, giving scientists a roadmap for understanding how it might work in humans.

This study was published in PLOS ONE, a reputable peer-reviewed journal, which means other scientists reviewed the work before publication. The researchers used a clear experimental design with control groups and measured many different outcomes. However, this is animal research only—mice don’t always respond the same way humans do to diet changes. The study was relatively short (4 weeks of diet intervention), so we don’t know if benefits would last longer. The researchers didn’t test different doses or durations of the ketogenic diet, so the optimal approach for humans remains unknown.

What the Results Show

Mice with thyroid disease that ate the ketogenic diet showed dramatic improvements across multiple measures. Antibodies attacking the thyroid (TgAb and TPOAb) decreased significantly, and inflammation markers in the blood dropped substantially. When researchers looked at thyroid tissue under a microscope, mice on the keto diet had much less immune cell infiltration—meaning fewer immune cells were attacking the thyroid gland.

The ketogenic diet also restored balance in the immune system. Specifically, it reduced Th17 cells (immune cells that promote inflammation) and increased Treg cells (immune cells that calm inflammation), bringing the ratio back toward normal. This rebalancing appears to be the key mechanism—the keto diet essentially helped the immune system stop attacking the thyroid.

At the molecular level, the keto diet suppressed several inflammation-promoting pathways, particularly the HMGB1/NLRP3 pathway, which acts like an alarm system that tells immune cells to attack. By quieting this alarm, the keto diet reduced the immune system’s aggressive response to the thyroid. Oxidative stress markers (signs of cellular damage) also improved, suggesting the keto diet protected thyroid cells from damage.

Beyond the main findings, researchers observed that the ketogenic diet reduced multiple inflammation chemicals in the blood, including TNF-α, IL-6, and IL-1β—all substances that fuel autoimmune attacks. The diet also improved antioxidant defenses, meaning the body’s natural protection against cellular damage was strengthened. These secondary findings suggest the keto diet works through multiple pathways, not just one mechanism.

Previous research has shown that the ketogenic diet can reduce inflammation in other conditions, but this is among the first studies examining its effects specifically on autoimmune thyroid disease. Other dietary approaches like elimination diets and anti-inflammatory diets have shown modest benefits for thyroid disease, but the keto diet appears to work through a different mechanism—by shifting immune cell balance rather than just reducing overall inflammation. This study builds on growing evidence that diet can influence autoimmune disease progression.

This research has several important limitations. First, it was conducted only in mice, which have different immune systems and metabolisms than humans—results may not translate directly. Second, the intervention was relatively short (4 weeks), so we don’t know if benefits persist long-term or if the immune system adapts over time. Third, the study didn’t test different versions of the ketogenic diet or compare it to other dietary approaches. Fourth, mice were given iodine to trigger thyroid disease, which is different from how autoimmune thyroid disease develops in humans. Finally, the study didn’t examine potential side effects or whether the keto diet might interfere with thyroid medications that people actually take.

The Bottom Line

Based on this research, the ketogenic diet shows promise as a potential complementary approach for autoimmune thyroid disease, but it’s too early to recommend it as a primary treatment. Anyone with thyroid disease considering the keto diet should: (1) consult their doctor first, as the diet may affect thyroid medication absorption and dosing; (2) have thyroid function monitored regularly if they try it; (3) understand this is experimental and human studies haven’t confirmed these mouse findings; (4) consider that the keto diet isn’t suitable for everyone, including pregnant women, people with certain metabolic disorders, or those taking specific medications. Confidence level: Low to Moderate (based on animal research only).

People with autoimmune thyroiditis (Hashimoto’s disease) might find this research interesting, particularly those seeking complementary approaches alongside standard treatment. People with other autoimmune conditions may also benefit from following this research. However, people with type 1 diabetes, certain kidney conditions, or those taking specific medications should avoid the keto diet without medical supervision. This research is not yet ready to guide treatment decisions—it’s primarily important for researchers planning human studies.

In the mouse study, improvements appeared within 4 weeks of starting the ketogenic diet. However, human bodies work differently than mouse bodies, and changes might take longer or be less dramatic. If human studies eventually confirm these findings, people would likely need to follow the diet consistently for several weeks before noticing improvements in symptoms or blood test results. It typically takes 6-12 weeks to see meaningful changes in thyroid antibody levels in humans.

Frequently Asked Questions

Can the ketogenic diet help treat Hashimoto’s thyroiditis?

A 2026 animal study suggests the keto diet may help by reducing thyroid inflammation and restoring immune balance, but this research was only in mice. Human studies are needed to confirm whether these benefits apply to people with Hashimoto’s disease. Anyone considering this diet should consult their doctor first.

How does the ketogenic diet affect the immune system in thyroid disease?

Research shows the keto diet appears to reduce Th17 immune cells (which attack the thyroid) and increase Treg cells (which calm inflammation), restoring immune balance. It also suppresses the HMGB1/NLRP3 inflammation pathway, which acts as an alarm system triggering immune attacks on thyroid tissue.

How long does it take to see results from the ketogenic diet for thyroid disease?

In the mouse study, improvements appeared within 4 weeks. However, human bodies may respond differently and more slowly. If human studies confirm these findings, people would likely need to follow the diet consistently for several weeks to months before noticing symptom improvements or changes in thyroid antibody levels.

Is the ketogenic diet safe for people taking thyroid medication?

The keto diet may affect how your body absorbs thyroid medications, potentially changing how much medication you need. Anyone taking thyroid medication should consult their doctor before starting the keto diet and have their thyroid function monitored regularly if they proceed.

What’s the difference between this research and other diets for thyroid disease?

This study shows the keto diet works by rebalancing immune cells (Th17 and Treg), whereas other diets mainly reduce overall inflammation. The keto diet’s specific mechanism of restoring immune balance appears unique, though human research is needed to confirm whether this translates to better outcomes than other dietary approaches.

Want to Apply This Research?

  • Users with autoimmune thyroid disease could track: (1) daily macronutrient ratios to ensure ketogenic diet compliance (targeting 70-75% fat, 20-25% protein, 5-10% carbs); (2) symptom severity scores (fatigue, brain fog, temperature sensitivity) on a 1-10 scale; (3) scheduled thyroid function test results (TSH, Free T4, antibody levels) every 6-8 weeks if their doctor approves dietary changes
  • If a user wants to explore this research-backed approach with medical approval, the app could: (1) provide a ketogenic diet meal planning template with thyroid-friendly foods; (2) send weekly reminders to log symptoms and energy levels; (3) create a simple chart showing trends in symptom severity over 8-12 weeks; (4) include a medication interaction checker to alert users if the keto diet might affect their thyroid medication timing or absorption
  • Long-term tracking should include: monthly symptom logs, quarterly thyroid function tests (coordinated with their doctor), and ongoing macronutrient tracking to ensure diet consistency. The app should flag any worsening symptoms or unusual changes in thyroid medication needs, prompting users to contact their healthcare provider. A 12-week check-in feature could help users decide whether to continue, modify, or discontinue the dietary approach based on their individual results.

This article summarizes animal research and is not medical advice. The ketogenic diet has not been proven effective for autoimmune thyroid disease in humans. Anyone with thyroid disease, particularly those taking thyroid medications, should consult their healthcare provider before making significant dietary changes. The keto diet is not appropriate for everyone and may interact with medications or underlying health conditions. This research represents early-stage findings that require human clinical trials before clinical recommendations can be made. Do not use this information to replace professional medical diagnosis or treatment.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: The ketogenic diet alleviates autoimmune thyroiditis caused by Th17/Treg imbalance by inhibiting the HMGB1/NLRP3 signaling pathway.PloS one (2026). PubMed 42102168 | DOI